AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.
19h
Verywell Health on MSNWhat Is SADI-S? A Newer Weight Loss Surgery That Removes 80% of the StomachInfluencer Remi Bader recently revealed she had a weight loss surgery called SADI-S to help her on her health journey. Here's ...
Your bellybutton may hold subtle signs about your digestion and gut health. Learn what to watch for and when to see a doctor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results